These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

278 related items for PubMed ID: 22223611

  • 1. Factor I autoantibodies in patients with atypical hemolytic uremic syndrome: disease-associated or an epiphenomenon?
    Kavanagh D, Pappworth IY, Anderson H, Hayes CM, Moore I, Hunze EM, Bennaceur K, Roversi P, Lea S, Strain L, Ward R, Plant N, Nailescu C, Goodship TH, Marchbank KJ.
    Clin J Am Soc Nephrol; 2012 Mar; 7(3):417-26. PubMed ID: 22223611
    [Abstract] [Full Text] [Related]

  • 2. Association of factor H autoantibodies with deletions of CFHR1, CFHR3, CFHR4, and with mutations in CFH, CFI, CD46, and C3 in patients with atypical hemolytic uremic syndrome.
    Moore I, Strain L, Pappworth I, Kavanagh D, Barlow PN, Herbert AP, Schmidt CQ, Staniforth SJ, Holmes LV, Ward R, Morgan L, Goodship TH, Marchbank KJ.
    Blood; 2010 Jan 14; 115(2):379-87. PubMed ID: 19861685
    [Abstract] [Full Text] [Related]

  • 3. Complement factor H-related protein 1 deficiency and factor H antibodies in pediatric patients with atypical hemolytic uremic syndrome.
    Hofer J, Janecke AR, Zimmerhackl LB, Riedl M, Rosales A, Giner T, Cortina G, Haindl CJ, Petzelberger B, Pawlik M, Jeller V, Vester U, Gadner B, van Husen M, Moritz ML, Würzner R, Jungraithmayr T, German-Austrian HUS Study Group.
    Clin J Am Soc Nephrol; 2013 Mar 14; 8(3):407-15. PubMed ID: 23243267
    [Abstract] [Full Text] [Related]

  • 4. Factor H-related protein 1 neutralizes anti-factor H autoantibodies in autoimmune hemolytic uremic syndrome.
    Strobel S, Abarrategui-Garrido C, Fariza-Requejo E, Seeberger H, Sánchez-Corral P, Józsi M.
    Kidney Int; 2011 Aug 14; 80(4):397-404. PubMed ID: 21677636
    [Abstract] [Full Text] [Related]

  • 5. Pulse cyclophosphamide therapy and clinical remission in atypical hemolytic uremic syndrome with anti-complement factor H autoantibodies.
    Boyer O, Balzamo E, Charbit M, Biebuyck-Gougé N, Salomon R, Dragon-Durey MA, Frémeaux-Bacchi V, Niaudet P.
    Am J Kidney Dis; 2010 May 14; 55(5):923-7. PubMed ID: 20202729
    [Abstract] [Full Text] [Related]

  • 6. Genetic analysis and functional characterization of novel mutations in a series of patients with atypical hemolytic uremic syndrome.
    Szarvas N, Szilágyi Á, Csuka D, Takács B, Rusai K, Müller T, Arbeiter K, Réti M, Haris Á, Wagner L, Török S, Kelen K, Szabó AJ, Reusz GS, Morgan BP, Prohászka Z.
    Mol Immunol; 2016 Mar 14; 71():10-22. PubMed ID: 26826462
    [Abstract] [Full Text] [Related]

  • 7. Atypical hemolytic uremic syndrome in children: complement mutations and clinical characteristics.
    Geerdink LM, Westra D, van Wijk JA, Dorresteijn EM, Lilien MR, Davin JC, Kömhoff M, Van Hoeck K, van der Vlugt A, van den Heuvel LP, van de Kar NC.
    Pediatr Nephrol; 2012 Aug 14; 27(8):1283-91. PubMed ID: 22410797
    [Abstract] [Full Text] [Related]

  • 8. Factor H autoantibody is associated with atypical hemolytic uremic syndrome in children in the United Kingdom and Ireland.
    Brocklebank V, Johnson S, Sheerin TP, Marks SD, Gilbert RD, Tyerman K, Kinoshita M, Awan A, Kaur A, Webb N, Hegde S, Finlay E, Fitzpatrick M, Walsh PR, Wong EKS, Booth C, Kerecuk L, Salama AD, Almond M, Inward C, Goodship TH, Sheerin NS, Marchbank KJ, Kavanagh D.
    Kidney Int; 2017 Nov 14; 92(5):1261-1271. PubMed ID: 28750931
    [Abstract] [Full Text] [Related]

  • 9. A novel hybrid CFH/CFHR3 gene generated by a microhomology-mediated deletion in familial atypical hemolytic uremic syndrome.
    Francis NJ, McNicholas B, Awan A, Waldron M, Reddan D, Sadlier D, Kavanagh D, Strain L, Marchbank KJ, Harris CL, Goodship TH.
    Blood; 2012 Jan 12; 119(2):591-601. PubMed ID: 22058112
    [Abstract] [Full Text] [Related]

  • 10. Thrombomodulin mutations in atypical hemolytic-uremic syndrome.
    Delvaeye M, Noris M, De Vriese A, Esmon CT, Esmon NL, Ferrell G, Del-Favero J, Plaisance S, Claes B, Lambrechts D, Zoja C, Remuzzi G, Conway EM.
    N Engl J Med; 2009 Jul 23; 361(4):345-57. PubMed ID: 19625716
    [Abstract] [Full Text] [Related]

  • 11. [Clinical characteristies of atypical hemolytie uremic syndrome associated with H factor antibody in children].
    Guan N, Liu X, Yao Y, Yang J, Wang F, Xiao H, Ding J, Zhao M, Yu F, Wang F.
    Zhonghua Er Ke Za Zhi; 2014 Mar 23; 52(3):223-6. PubMed ID: 24824395
    [Abstract] [Full Text] [Related]

  • 12. Screening for complement system abnormalities in patients with atypical hemolytic uremic syndrome.
    Kavanagh D, Richards A, Fremeaux-Bacchi V, Noris M, Goodship T, Remuzzi G, Atkinson JP.
    Clin J Am Soc Nephrol; 2007 May 23; 2(3):591-6. PubMed ID: 17699467
    [No Abstract] [Full Text] [Related]

  • 13. Combined complement gene mutations in atypical hemolytic uremic syndrome influence clinical phenotype.
    Bresin E, Rurali E, Caprioli J, Sanchez-Corral P, Fremeaux-Bacchi V, Rodriguez de Cordoba S, Pinto S, Goodship TH, Alberti M, Ribes D, Valoti E, Remuzzi G, Noris M, European Working Party on Complement Genetics in Renal Diseases.
    J Am Soc Nephrol; 2013 Feb 23; 24(3):475-86. PubMed ID: 23431077
    [Abstract] [Full Text] [Related]

  • 14. Overactivation of Complement Alternative Pathway in Postpartum Atypical Hemolytic Uremic Syndrome Patients with Renal Involvement.
    Song D, Yu XJ, Wang FM, Xu BN, He YD, Chen Q, Wang SX, Yu F, Song WC, Zhao MH.
    Am J Reprod Immunol; 2015 Oct 23; 74(4):345-56. PubMed ID: 26011580
    [Abstract] [Full Text] [Related]

  • 15. Anti factor H autoantibodies block C-terminal recognition function of factor H in hemolytic uremic syndrome.
    Józsi M, Strobel S, Dahse HM, Liu WS, Hoyer PF, Oppermann M, Skerka C, Zipfel PF.
    Blood; 2007 Sep 01; 110(5):1516-8. PubMed ID: 17495132
    [Abstract] [Full Text] [Related]

  • 16. Genetics and complement in atypical HUS.
    Kavanagh D, Goodship T.
    Pediatr Nephrol; 2010 Dec 01; 25(12):2431-42. PubMed ID: 20526633
    [Abstract] [Full Text] [Related]

  • 17. Heterogeneity but individual constancy of epitopes, isotypes and avidity of factor H autoantibodies in atypical hemolytic uremic syndrome.
    Nozal P, Bernabéu-Herrero ME, Uzonyi B, Szilágyi Á, Hyvärinen S, Prohászka Z, Jokiranta TS, Sánchez-Corral P, López-Trascasa M, Józsi M.
    Mol Immunol; 2016 Feb 01; 70():47-55. PubMed ID: 26703217
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Characterization of complement factor H-related (CFHR) proteins in plasma reveals novel genetic variations of CFHR1 associated with atypical hemolytic uremic syndrome.
    Abarrategui-Garrido C, Martínez-Barricarte R, López-Trascasa M, de Córdoba SR, Sánchez-Corral P.
    Blood; 2009 Nov 05; 114(19):4261-71. PubMed ID: 19745068
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.